Medtronic Gears For Stent Patent Infringement Showdowns With J&J, Guidant
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's Endeavor drug-eluting stent program and current coronary stent line-up are unaffected by a recent Johnson & Johnson patent infringement ruling against the company, Medtronic insists